טוען...
Anti-CD73 in cancer immunotherapy: awakening new opportunities
In recent years, cancer immunotherapy made significant advances due to a better understanding of the principles underlying tumor biology and immunology. In this context, CD73 is a key molecule, since via degradation of adenosine monophosphate into adenosine, endorses the generation of an immunosuppr...
שמור ב:
| הוצא לאור ב: | Trends Cancer |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4800751/ https://ncbi.nlm.nih.gov/pubmed/27014745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trecan.2016.01.003 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|